NAMSA Expands Medical Device Testing Services in Germany to Increase Access to Accelerated Product Development
NAMSA ® , the world’s only Medical Research Organization (MRO ) that accelerates medical device development through integrated testing, clinical research and regulatory consulting services, is pleased to announce the launch of its state-of-the-art Analytical Services Laboratory in Obernburg, Germany. The opening of this laboratory represents the organization’s fourth European location and NAMSA’s growing investment in Europe’s largest medical device market.
The new facility, located one hour from Frankfurt, will offer European device manufacturers a centrally-located site for ISO 10993-18 testing requirements and provide further conveniences for exhaustive extraction, FTIR, GC-MS, LC-MS and ICP-MS services in the region.
“NAMSA is excited to add to its global portfolio of services with the introduction of its new Obernburg laboratory,” commented Ulrich Gohlke, Director of German Lab Operations, NAMSA. “NAMSA is proud of its strong working relationships with EU regulatory entities, including the European Commission, and demonstrated track record of delivering significant time and cost savings throughout the medical device development continuum. With the introduction of NAMSA’s new Analytical Services Laboratory, we look forward to providing European device makers significant development efficiencies, including closer collaboration through an ideally-located testing partner.”
NAMSA is a leading Contract Research Organization (CRO) – and the world’s only Medical Device Organization (MRO) – that supports clients throughout all stages of the medical device development lifecycle. From concept and feasibility testing to post-market surveillance, services provided by NAMSA have been proven to accelerate time-to-market and reduce costs for product research and market introduction. By leveraging a half century of technical expertise, and drawing upon 1,000 highly knowledgeable global Associates, NAMSA is the industry leader in balancing speed and quality with proven scientific approaches.
Grand Opening Celebration
NAMSA will celebrate the launch of its new Analytical Services Laboratory with a special Grand Opening celebration 6 March 2018 (14:00 – 20:00 CET). Featured will be laboratory tours, complimentary consultations, scientific sessions, keynote addresses and a networking reception. If you are interested in learning more about this event, or would like to register, please visit our website .
NAMSA is a Medical Research Organization (MRO), accelerating medical device product development through integrated laboratory, clinical research and regulatory consulting services. Driven by our regulatory expertise, NAMSA’s MRO® Approach plays an important role in translational research, applying a unique combination of disciplines – consulting, regulatory, preclinical, toxicology, microbiology, chemistry, clinical and quality – to move clients’ products through the development process, and continue to provide support through commercialization to post-market requirements anywhere in the world.
NAMSA operates 14 offices throughout Asia, Europe, the Middle East and North America, and employs over 1,000 highly-experienced laboratory, clinical and consulting Associates.
Leah Davidson, MA, MBA, 612-615-6985
Marketing Communications Manager
Information om Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco
Følg pressemeddelelser fra Business Wire
Skriv dig op her, og modtag pressemeddelelser på e-mail. Indtast din e-mail, klik på abonner, og følg instruktionerne i den udsendte e-mail.
Flere pressemeddelelser fra Business Wire
ABB19.1.2019 10:02 | Pressemeddelelse
Warm welcome for ABB Formula E in Davos
PHILIP-MORRIS-INTERNATIO18.1.2019 18:02 | Pressemeddelelse
PMI’s Mission Winnow Goes Full Throttle with Ducati Corse for 2019 MotoGP™
NY-IFF18.1.2019 13:52 | Pressemeddelelse
IFF’s Frutarom Division Completes Acquisition of 60% of Thailand-based Mighty
LARSEN-&-TOUBRO-INFOTECH18.1.2019 13:04 | Pressemeddelelse
LTI Q3 FY19: Constant currency revenue growth up 6.1% QoQ and 20.6% YoY; Net Profit jumps 32.8% YoY
TX-SCHLUMBERGER-LIMITED18.1.2019 13:02 | Pressemeddelelse
Schlumberger Announces Full-Year and Fourth-Quarter 2018 Results
OR-FLIR-SYSTEMS18.1.2019 12:02 | Pressemeddelelse
FLIR Systems Awarded $89 Million Contract from French Armed Forces to Deliver Black Hornet Personal Reconnaissance System
I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter samt finde vores kontaktoplysninger.Besøg vores nyhedsrum